Abstract:Hematoxylin and eosin (H&E) whole slide images provide valuable information for predicting prognostic outcomes in colorectal cancer (CRC) patients. However, extracting prognostic indicators from pathological images is challenging due to the subtle complexities of phenotypic information. We trained a weakly supervised deep learning model on data from 640 CRC patients in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial dataset and validated it using data from 522 CRC patients in the cancer genome atlas (TCGA) dataset. We created the colorectal cancer risk score (CRCRS) to assess patient prognosis, visualized the pathological phenotype of the risk score using Grad-CAM, and employed multiomics data from the TCGA CRC cohort to investigate the potential biological mechanisms underlying the risk score. The overall survival analysis revealed that the CRCRS served as an independent prognostic indicator for both the PLCO cohort (p < 0.001) and the TCGA cohort (p < 0.001), with its predictive efficacy remaining unaffected by the clinical staging system. Additionally, satisfactory chemotherapeutic benefits were observed in stage II/III CRC patients with high CRCRS but not in those with low CRCRS. A pathomics nomogram constructed by integrating the CRCRS with the tumor-node-metastasis (TNM) staging system enhanced prognostic prediction accuracy compared with using the TNM staging system alone. Noteworthy features of the risk score were identified, such as immature tumor mesenchyme, disorganized gland structures, small clusters of cancer cells associated with unfavorable prognosis, and infiltrating inflammatory cells associated with favorable prognosis. The TCGA multiomics data revealed potential correlations between the CRCRS and the activation of energy production and metabolic pathways, the tumor immune microenvironment, and genetic mutations in APC, SMAD2, EEF1AKMT4, EPG5, and TANC1. In summary, our deep learning algorithm identified the CRCRS as a prognostic indicator in CRC, providing a significant approach for prognostic risk stratification and tailoring precise treatment strategies for individual patients.

Using Machine Learning Methods to Study Colorectal Cancer Tumor Micro-Environment and Its Biomarkers.

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Identification Of Potential Biomarkers For Risk Analysis Of Colorectal Cancer Using A Combined Bioinformatics Analysis

Patterns of Gene Expression Profiles Associated with Colorectal Cancer in Colorectal Mucosa by Using Machine Learning Methods.

Application of RNA Processing Factors for Predicting Clinical Outcomes in Colon Cancer.

A Novel Approach to Biomarker Discovery: Four Key Genes as High-Performance Biomarkers for Colorectal Cancer

Construction of a Colorectal Cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms

Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms

Identification of Colon Immune Cell Marker Genes Using Machine Learning Methods.

Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis

Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients: a novel machine learning survival predictive system

Accurate prediction of colorectal cancer diagnosis using machine learning based on immunohistochemistry pathological images

Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis

Integrating machine learning and bioinformatics approaches for identifying novel diagnostic gene biomarkers in colorectal cancer

Enhancing metastatic colorectal cancer prediction through advanced feature selection and machine learning techniques

Exploring prognostic biomarkers in pathological images of colorectal cancer patients via deep learning

Identification of Methylation Driven Biomarkers for Diagnosis and Prognosis in Colorectal Cancer by Integrative Analysis of TCGA, GTEx, and GEO Database

SNPs and Blood Inflammatory Marker Featured Machine Learning for Predicting the Efficacy of Fluorouracil-Based Chemotherapy in Colorectal Cancer

Prognostic model development for classification of colorectal adenocarcinoma by using machine learning model based on feature selection technique boruta

Unveiling Prognostic RNA Biomarkers through a Multi-Cohort Study in Colorectal Cancer

Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer